Although the EULAR/ACR criteria do not mention the presence or absence of ILD, suspicion of IIM is important in patients with ILD because, as mentioned above, early treatment is crucial in ASS and anti-MDA5 antibody-positive ILD. This evidence concerns the gene IFIH1 and acquired idiopathic inflammatory myopathy.